XRME:F:F-Xtrackers MSCI USA ESG Screened UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.295

Change

-0.22 (-2.31)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.55 (-1.07%)

USD 114.12B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.94 (+0.16%)

USD 99.24B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.03B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.85 (-0.77%)

USD 59.61B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.16 (-1.06%)

USD 54.27B
VUSA:F Vanguard Funds Public Limited ..

+0.10 (+0.09%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.03 (-0.35%)

USD 40.33B
0ZC:F Zscaler Inc

+0.56 (+0.32%)

USD 37.92B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.12 (-0.09%)

USD 24.77B
SXRV:F iShares NASDAQ 100 UCITS ETF U..

+13.20 (+1.25%)

USD 15.89B

ETFs Containing XRME:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.79% 75% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.79% 72% C 60% D-
Trailing 12 Months  
Capital Gain 18.82% 79% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.82% 76% C+ 66% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.18% 77% C+ 72% C
Dividend Return 10.18% 75% C 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.76% 57% F 83% B
Risk Adjusted Return 86.58% 94% A 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike